Prof. Frankel (London, UK)
- Boehringer Ingelheim
- HCP Portal
- Products
- Trajenta®
- Resources
- Prof. Frankel (London, UK)
Prof. Frankel (London, UK)
Published 14.08.2019 by Boehringer Ingelheim
Trajenta®’s convenience of 5mg once daily, for a broad range of people with T2D.
Transcript
Trajenta offers me, and indeed all physicians caring for people with diabetes, a convenient once daily treatment. Trajenta can be prescribed at 5 milligrams, once daily for the broad range of people with type 2 diabetes. And I would highlight that there is no requirement to undertake any additional monitoring over and above that which you would usually undertake in a person with diabetes. This adds to the simplicity when using Trajenta in primary care, which is important because of the significant pressure that primary care face with the growing burden of people with type 2 diabetes.
